eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
6/2023
vol. 15
 
Share:
Send email
Share:
abstract:
Original paper

Current status and future readiness of Indian radiation oncologists to embrace prostate high-dose-rate brachytherapy: An Indian Brachytherapy Society survey

Susovan Banerjee
1
,
Soumya Sarkar
1
,
Umesh Mahantshetty
2
,
Sorun Shishak
1
,
Venkatesan Kaliyaperumal
1
,
Shyam Singh Bisht
1
,
Deepak Gupta
1
,
Kushal Narang
1
,
Mayur Mayank
1
,
V Srinivasan
3
,
Vivek Anand
4
,
Kanhu Charan Patro
5
,
Rajiv Ranjan Prasad
6
,
Tejinder Kataria
1

  1. Division of Radiation Oncology, Medanta – The Medicity, Sector 38, Gurgaon, Haryana, India
  2. Department of Radiation Oncology, Homi Bhaba Cancer Hospital and Research Centre, Tata Memorial Centre, Vizag, India
  3. Department of Radiation Oncology, MIOT International Hospital, Chennai, India
  4. Department of Radiation Oncology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
  5. Department of Radiation Oncology, Mahatma Gandhi Cancer Hospital, Vizag, India
  6. Division of Radiation Oncology, Jay Prabha Medanta Super Specialty Hospital, Kankarbagh, Patrakar Nagar, Patna, Bihar, India
J Contemp Brachytherapy 2023; 15, 6: 391–398
DOI: https://doi.org/10.5114/jcb.2023.134168
Online publish date: 2023/12/29
View full text Get citation
 
Purpose:
This survey aimed to understand the practice pattern and attitude of Indian doctors towards prostate brachytherapy.

Material and methods:
A 21-point questionnaire was designed in Google form and sent to radiation oncologists practicing in India, using texts, mails, and social media. Responses were collated, and descriptive statistical analysis was performed.

Results:
A total of 212 radiation oncologists from 136 centers responded to the survey questionnaire, with majority (66%) being post-specialty training > 6 years. We found that about 44.3% (n = 94) of respondents do not practice interstitial brachytherapy for any site, and majority (83.3%, n = 175) do not practice high-dose-rate (HDR) prostate brachytherapy. Only 2.8% (n = 6) of doctors preferred boost by brachytherapy compared with 38.1% (n = 80) of respondents, who favored stereotactic body radiation therapy (SBRT) boost. When asked about the indication of HDR prostate brachytherapy in Indian setting, 32.5% (n = 67) of respondents favored monotherapy, 46.1% (n = 95) of oncologists thought boost as a good indication, and 21.4% (n = 44) preferred re-irradiation/salvage setting. The most cited reason for prostate brachytherapy not being popularly practiced in India was lack of training (84.8%, n = 179). It was also noted that out of 80 respondents who practiced SBRT for prostate boost, 37 would prefer HDR brachytherapy boost if given adequate training and facilities.

Conclusions:
The present survey provided insight on practice of prostate brachytherapy in India. It is evident that majority of radiation oncologists do not practice HDR prostate brachytherapy due to lack of training and infrastructure. Indian physicians are willing to learn and start prostate brachytherapy procedures if dedicated training and workshops are organized.

keywords:

prostate, brachytherapy, survey

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.